Long-Term Effects of Furosemide and Hydrochlorothiazide in Patients With Essential Hypertension

Author:

Finnerty Frank A.,Maxwell Morton H.,Lunn John,Moser Marvin

Abstract

In a double-blind study the long-term effects of diuretics in uncompli cated mild and moderate essential hypertension were investigated. A total of 52 outpatients completed 24 months of treatment with either furose mide at a dose of 40 mg twice daily (26 patients) or hydrochlorothiazide at a dose of 50 mg twice daily (26 patients). Throughout the 2 years of the study, both furosemide and hydro chlorothiazide significantly lowered the mean supine blood pressure from baseline levels. The fall was less with furosemide than with hydrochloro thiazide, although the difference between the two drugs reached statistical significance at only three of the eight time points. Serum electrolytes were used as major indicators of safety. The cumulative incidence of hypokalemia of 8% for the furosemide group compared to that of 62% for the hydrochlorothiazide group. Although diuretics, alone or combined with other blood pressure-lower ing drugs, have been used for many years to treat essential hypertension, information on their continued efficacy and safety is scarce. Short-term trials had shown that furosemide (Lasix(®)) resembled the thiazides in its antihypertensive properties,1-3 despite its different mode of action on the kidney. A cooperative study in hypertensive patients was therefore under taken at three clinical centers to investigate the long-term effects of furose mide on blood pressure and on serum electrolytes, and to compare them with those of hydrochlorothiazide.

Publisher

SAGE Publications

Subject

Cardiology and Cardiovascular Medicine

Cited by 51 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Diuretics for Hypertension in Asians;Hypertension and Cardiovascular Disease in Asia;2022

2. Torasemide in Hypertension and Heart Failure: Re-inventing Loop Diuretic Therapy?;Current Pharmaceutical Design;2021-09-09

3. Hypertensive Chronic Kidney Disease;Chronic Kidney Disease, Dialysis, and Transplantation;2019

4. Clinical Pharmacology of Antihypertensive Therapy for the Treatment of Hypertension in CKD;Clinical Journal of the American Society of Nephrology;2018-11-13

5. Medications that cause weight gain and alternatives in Canada: a narrative review;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2018-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3